ENDRA Life Sciences (NDRA) Enterprise Value (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Enterprise Value for 10 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 194.86% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 194.86% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 242.69% from the prior year.
• Enterprise Value was $2.5 million for Q2 2026 at ENDRA Life Sciences, down from $5.4 million in the prior quarter.
• Over five years, Enterprise Value peaked at $668.6 million in Q3 2022 and troughed at -$3.0 million in Q3 2024.
• A 5-year average of $213.9 million and a median of $153.3 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value slumped 100.93% in 2024 and soared 2153.56% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at $446.5 million in 2022, then gained by 5.11% to $469.4 million in 2023, then tumbled by 100.42% to -$2.0 million in 2024, then soared by 242.69% to $2.8 million in 2025, then fell by 12.44% to $2.5 million in 2026.
• The last three Enterprise Value figures came in at $2.5 million (Q2 2026), $5.4 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.